
The National Cancer Institutes and the academic institutions with whom we collaborate have the scientists, the expertise, and the laboratory facilities to support and help us conduct required preclinical and clinical studies, but they cannot give us financial assistance.
As a non-profit public charity, we must provide the funds to enable our projects to become a reality.
We rely solely on your compassion and generosity for public contributions to accomplish our mission. So that we may develop new treatments against HIV and cancers in dogs and humans, we urgently need your charitable and tax-deductable contribution.
Thank you for your compassion, your help, and your generosity.
Nearly 50 million people in America have pet dogs. And more than half the dogs older than ten years will die of cancer.
Let There Be Hope is working to develop on a new anti-cancer immune therapy to treat our beloved pets, which may also lead to a breakthrough treatment for humans.
Dog cancers are quite similar to human cancers. So this approach will allow promising new treatments to be developed much more quickly, skipping other laboratory and animal tests and getting treatment to both pets and human cancer patients faster.
Let There Be Hope is sponsoring the clinical development of this treatment for use in both pet dogs and humans.
Infectious viral reservoirs permit continuous reinfection of people, even in the absence of viremia or active viral replication with current state-of-the-art treatment regimes. Development of a treatment that attacks the HIV reservoirs as well as limits viral fusion to target cells holds promise for a major step in the fight to eradicate HIV and control the spread of disease. Using a broad-spectrum plant-derived antiviral compound isolated and developed at the National Cancer Institute, when targeted to the intracellular compartments of cells containing HIV reservoirs, infectious spread to target cells has been shown to be completely eliminated. Let There Be Hope is sponsoring a preclinical study in the SCID mouse model of HIV to develop additional preclinical evidence to move forward into human clinical trials.
Thank you for your compassion, your help, and your generosity.
Michael J. Scolaro, M.D. Board Chair
Let There Be Hope Medical Research Institute,
a 501 (c) 3 Nonprofit Public Charity
Tax I.D. # 95-4438105
Email: mscolaro@LetThereBeHope.org